ResMed has secured FDA clearance for its Personalized Therapy Comfort Settings (PTCS), branded as Smart Comfort, marking a significant step in AI-driven sleep apnea treatment. The clearance could ...
Boston Scientific BSX and Resmed RMD are two major players in the global medical devices market, with market capitalizations of $142.4 billion and $35.72 billion, respectively. Marlborough, MA-based ...
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.
WASHINGTON – AdvaMed has announced that Mick Farrell, chairman and CEO of Resmed, will be the next chair of the AdvaMed board of directors. Farrell, who will serve a two-year term beginning in January ...
Is RMD the next big buy?
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback